Literature DB >> 9312273

Glycosylation affects both the three-dimensional structure and antibody binding properties of the HIV-1IIIB GP120 peptide RP135.

X Huang1, J J Barchi, F D Lung, P P Roller, P L Nara, J Muschik, R R Garrity.   

Abstract

We have prepared glycosylated analogues of the principal neutralizing determinant of gp120 and studied their conformations by NMR and circular dichroism spectroscopies. The 24-residue peptide from the HIV-1IIIB isolate (residues 308-331) designated RP135, which contains the immunodominant tip of the V3 loop, was glycosylated with both N- and O-linked sugars. The structures of two glycopeptides, one with an N-linked beta-glucosamine (RP135NG) and the other with two O-linked alpha-galactosamine units (RP135digal), were studied by NMR and circular dichroism spectroscopies. Molecular dynamics calculations based on the NMR data obtained in water solutions were performed to explore the conformational substates sampled by the glycopeptides. The data showed that covalently linking a carbohydrate to the peptide has a major effect on the local conformation and imparts additional minor changes at more distant sites of partially defined secondary structure. In particular, the transient beta-type turn comprised of the -Gly-Pro-Gly-Arg- segment at the "tip" of the V3 loop is more highly populated in RP135digal that in the native peptide and N-linked analogue. Binding data for the glycopeptides with 0.5beta, a monoclonal antibody mapped to the RP135 sequence, revealed a significant enhancement in binding for RP135digal as compared with the native peptide, whereas binding was reduced for the N-linked glycopeptide. These data show that glycosylation of V3 loop peptides can affect their conformations as well as their interactions with antibodies. The design of more ordered and biologically relevant conformations of immunogenic regions from gp120 may aid in the design of more effective immunogens for HIV-1 vaccine development.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9312273     DOI: 10.1021/bi9703655

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  17 in total

1.  Probing cell-surface architecture through synthesis: an NMR-determined structural motif for tumor-associated mucins.

Authors:  D H Live; L J Williams; S D Kuduk; J B Schwarz; P W Glunz; X T Chen; D Sames; R A Kumar; S J Danishefsky
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-30       Impact factor: 11.205

2.  Crystal structures of human immunodeficiency virus type 1 (HIV-1) neutralizing antibody 2219 in complex with three different V3 peptides reveal a new binding mode for HIV-1 cross-reactivity.

Authors:  Robyn L Stanfield; Miroslaw K Gorny; Susan Zolla-Pazner; Ian A Wilson
Journal:  J Virol       Date:  2006-06       Impact factor: 5.103

3.  Glycan-Dependent Neutralizing Antibodies Are Frequently Elicited in Individuals Chronically Infected with HIV-1 Clade B or C.

Authors:  Yehuda Z Cohen; Christy L Lavine; Caroline A Miller; Jetta Garrity; Brittany R Carey; Michael S Seaman
Journal:  AIDS Res Hum Retroviruses       Date:  2015-08-05       Impact factor: 2.205

4.  Allergenicity of carbohydrates and their role in anaphylactic events.

Authors:  Scott P Commins; Thomas A E Platts-Mills
Journal:  Curr Allergy Asthma Rep       Date:  2010-01       Impact factor: 4.806

5.  Synthesis and cell-selective antitumor properties of amino acid conjugated tumor-associated carbohydrate antigen-coated gold nanoparticles.

Authors:  Souvik Biswas; Scott H Medina; Joseph J Barchi
Journal:  Carbohydr Res       Date:  2014-12-03       Impact factor: 2.104

6.  Hepatitis C virus envelope glycoprotein co-evolutionary dynamics during chronic hepatitis C.

Authors:  Hui Li; Brian J McMahon; Susan McArdle; Dana Bruden; Daniel G Sullivan; Dave Shelton; Heike Deubner; David R Gretch
Journal:  Virology       Date:  2008-03-17       Impact factor: 3.616

7.  Glycosylation patterns of HIV-1 gp120 depend on the type of expressing cells and affect antibody recognition.

Authors:  Milan Raska; Kazuo Takahashi; Lydie Czernekova; Katerina Zachova; Stacy Hall; Zina Moldoveanu; Matt C Elliott; Landon Wilson; Rhubell Brown; Dagmar Jancova; Stephen Barnes; Jana Vrbkova; Milan Tomana; Phillip D Smith; Jiri Mestecky; Matthew B Renfrow; Jan Novak
Journal:  J Biol Chem       Date:  2010-05-03       Impact factor: 5.157

8.  Comparative study of adaptive molecular evolution in different human immunodeficiency virus groups and subtypes.

Authors:  Marc Choisy; Christopher H Woelk; Jean-François Guégan; David L Robertson
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

9.  Metastasis of cholangiocarcinoma is promoted by extended high-mannose glycans.

Authors:  Diane Dayoung Park; Chatchai Phoomak; Gege Xu; Laura P Olney; Khiem A Tran; Simon S Park; Nathan E Haigh; Guillaume Luxardi; Worachart Lert-Itthiporn; Michiko Shimoda; Qiongyu Li; Nobuyuki Matoba; Fernando Fierro; Sopit Wongkham; Emanual Maverakis; Carlito B Lebrilla
Journal:  Proc Natl Acad Sci U S A       Date:  2020-03-25       Impact factor: 11.205

10.  B cells and monocytes from patients with active multiple sclerosis exhibit increased surface expression of both HERV-H Env and HERV-W Env, accompanied by increased seroreactivity.

Authors:  Tomasz Brudek; Tove Christensen; Lars Aagaard; Thor Petersen; Hans J Hansen; Anné Møller-Larsen
Journal:  Retrovirology       Date:  2009-11-16       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.